AVIR   $3.675  -4.05% Market Closed After Close 3.67 -0.14%

Atea Pharmaceuticals Inc
Total Cash 502.21M
totalCashPerShare 5.949
EBITDA -123.65M
Total Debt 2.02M
quickRatio 18.867
currentRatio 19.023
Total Revenue
debtToEquity 0.425
Revenue/Share
ROA -0.13646
ROE -0.32628
grossProfits
freeCashflow -8.25M
operatingCashflow -121.49M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -173.48M
forwardPE -1.7926267
floatShares 60.01M
sharesOutstanding 84.42M
sharesShort 2.83M
sharesShortPriorMonth 2.38M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.70%
Short Ratio help_outline 13.02%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 5.644
Price To Book help_outline 0.69
earningsQuarterlyGrowth
netIncomeToCommon -176.00M
trailingEps -2.10%
forwardEps -2.17%
enterpriseToEbitda 1.40
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.5 3Q 2024
institutionsCount 148
lastUpdated Sept. 16, 2024, 8:05 p.m.